HomeTagsC2N Diagnostics

C2N Diagnostics

Biotechnology

C2N Diagnostics Releases the PrecivityAD2™ Blood Test for Clinical Care, a Robust Assay with High Concordance to Amyloid PET and CSF

News Desk - August 18, 2023

C2N Diagnostics, a leader in advanced brain health diagnostics, announced the release of the PrecivityAD2 blood test, a clinical care assay that meets the...

Healthcare

C2N Diagnostics’ Precivity-Related Blood Biomarkers Shown to Improve Diagnostic Accuracy and Future Risk Prediction of Alzheimer’s Disease in Two Studies Presented at AD/PD 2023

Business Wire - April 5, 2023

C2N Diagnostics, a leader in advanced brain health diagnostics, announced the presentation of two research studies at the AD/PD 2023 International Conference on Alzheimer’s...

Healthcare

C2N and Eisai Collaborate to Build Awareness and Real-World Evidence

PR Newswire - August 24, 2022

C2N Diagnostics and Eisai Inc. announced the Companies have entered into a memorandum of understanding that will seek to build awareness about how blood-based...

TransNetwork acquires Inswitch to drive the future of banking and cross-border…

Princeton NuEnergy (PNE) Raises Additional $10.3 Million in Series A Funding…

Grip launches Pulse, a next generation Order Management System for perishable…

GE HealthCare and Medis Medical Imaging Announce Collaboration Focused on Non-Invasive…

C2N Diagnostics

Hot Topics

E-Pharmacy: Redefining the Way We Access and Manage Medications

TransNetwork acquires Inswitch to drive the future of banking and cross-border digital payments in Latin America

Princeton NuEnergy (PNE) Raises Additional $10.3 Million in Series A Funding to Advance Lithium-ion Battery Direct Recycling Technology